Germany
Japan
United Kingdom
China
RNP Antigen human polyclonal antibody, Purified
| Applications | ELISA, ID, WB |
| Reactivities | Human |
Primary Antibodies
View as table DownloadTopoisomerase I (TOP1) human polyclonal antibody, Purified
| Applications | ELISA, ID, WB |
| Reactivities | Human |
Dystonin (DST) human monoclonal antibody, clone H5E.Hy.4B
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Dystonin (DST) human monoclonal antibody, clone H10D-Hy-8B
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BETVIA human monoclonal antibody, clone H.G5F2A4.09
| Applications | ELISA, WB |
| Reactivities | Pollen |
USD 600.00
2 Weeks
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AK6.A3.F4
| Applications | ELISA, WB |
USD 600.00
2 Weeks
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AA.IV7A3
| Applications | ELISA, WB |
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AK5.C
| Applications | ELISA, WB |
SARS-CoV-2 N protein monoclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
| Conjugation | His Tag |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Phl p 1 (Clone Clone 25)
| Applications | ELISA, WB |
| Reactivities | Rat |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Applications
- WB
Antibody Hosts
- Human
Filter by
Category
Target Symbol
Reactivities
Clonalities
Conjugates
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)